blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1748997

EP1748997 - SUBSTITUTED THIOPHENE-2-CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE THEREOF AS DRUGS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.04.2011
Database last updated on 02.11.2024
Most recent event   Tooltip29.04.2011Application deemed to be withdrawnpublished on 01.06.2011  [2011/22]
Applicant(s)For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim / DE
[N/P]
Former [2007/37]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim / DE
Former [2007/06]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  MC  NL  PL  PT  RO  SE  SI 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim / DE
Inventor(s)01 / PFAU, Roland
Pfluggasse 15
88400 BIBERACH / DE
02 / PRIEPKE, Henning
Birkenharderstr. 11
88447 WARTHAUSEN / DE
03 / GERLACH, Kai
Mondstrasse 18/1
88400 BIBERACH / DE
04 / WIENEN, Wolfgang
Kirschenweg 27
88400 BIBERACH / DE
05 / SCHULER-METZ, Annette
Holzgasse 7
89081 ULM / DE
06 / NAR, Herbert
Hexenweg 19
88416 OCHSENHAUSEN / DE
07 / HANDSCHUH, Sandra
Schustergasse 3
88447 WARTHAUSEN / DE
 [2007/06]
Representative(s)Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH
CD-Patents
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2007/06]Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH, CD-Patents, Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date05745599.007.05.2005
[2007/06]
WO2005EP04974
Priority number, dateEP2004001138713.05.2004         Original published format: EP 04011387
[2007/06]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2005111013
Date:24.11.2005
Language:DE
[2005/47]
Type: A1 Application with search report 
No.:EP1748997
Date:07.02.2007
Language:DE
The application published by WIPO in one of the EPO official languages on 24.11.2005 takes the place of the publication of the European patent application.
[2007/06]
Search report(s)International search report - published on:EP24.11.2005
ClassificationIPC:C07D333/38, C07D413/12, C07D409/12, A61K31/551, A61P7/02
[2007/06]
CPC:
C07D333/38 (EP,US); A61P43/00 (EP); A61P7/02 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/06]
Extension statesALNot yet paid
BA13.12.2006
HR13.12.2006
LVNot yet paid
MKNot yet paid
YU13.12.2006
TitleGerman:SUBSTITUIERTE THIOPHEN-2-CARBONSÄUREAMIDE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL[2007/06]
English:SUBSTITUTED THIOPHENE-2-CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE THEREOF AS DRUGS[2007/06]
French:AMIDES D'ACIDE THIOPHENE-2-CARBOXYLIQUE SUBSTITUES, LEUR PRODUCTION ET LEUR UTILISATION COMME MEDICAMENT[2007/06]
Entry into regional phase13.12.2006National basic fee paid 
13.12.2006Designation fee(s) paid 
13.12.2006Examination fee paid 
Examination procedure13.12.2006Examination requested  [2007/06]
12.05.2009Despatch of a communication from the examining division (Time limit: M06)
23.03.2010Reply to a communication from the examining division
01.12.2010Application deemed to be withdrawn, date of legal effect  [2011/22]
14.01.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2011/22]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.05.2009
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
23.03.2010Request for further processing filed
23.03.2010Full payment received (date of receipt of payment)
Fees paidRenewal fee
31.05.2007Renewal fee patent year 03
02.06.2008Renewal fee patent year 04
02.06.2009Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.201006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO0147919  (BAYER AG [DE], et al) [Y] 1-17 * Zusammenfassung; Seite 4, Zeilen 16-19; Ansprüche; und unter anderem Beispiele 1-5, 9, 13, 44. *;
 [A]WO0196303  (LILLY CO ELI [US], et al) [A] 1-17 * Zusammenfassung; Ansprüche; Seite 11, Zeilen 3-4 und 11-12; Seite 34, Zeilen 23-24 und Seite 35, Thiophen-Struktur (B'). *;
 [A]WO0248099  (MERCK PATENT GMBH [DE], et al) [A] 1-17* Zusammenfassung; Ansprüche; Beispiele. *;
 [Y]WO2004031145  (BRISTOL MYERS SQUIBB CO [US], et al) [Y] 1-17 * Zusammenfassung; Ansprüche; z.B. Anspruch 4 (Verbindungen d1 mit G = 5-Chlorthien-2-yl und A = Phenyl subst. mit 0-2 R4), Beispiele 436 und 437. *;
 [PX]WO2004046138  (MERCK PATENT GMBH [DE], et al) [PX] 1-17 * Zusammenfassung; Ansprüche 1-18; Beispiele; Seite 53, Pharmakologische Daten. *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.